COMMUNIQUÉS West-GlobeNewswire
-
Galimedix Therapeutics outlines development plans in Alzheimer's disease at CTAD 2026
16/11/2026 -
Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026
16/11/2026 -
Diakonos Oncology Presents DOC1021 Data Showing Encouraging Survival Signal in Newly Diagnosed Glioblastoma at SNO 2026
16/11/2026 -
HealthEdge Introduces AI Strategy to Protect Health Plans From Unpredictable AI Costs
16/11/2026 -
Four students, one shared goal: a healthier Saskatchewan
16/11/2026 -
Vaso Corporation Announces Financial Results for Third Quarter of 2026
16/11/2026 -
Tris Pharma Named a BioSpace 2027 Best Places to Work Winner
16/11/2026 -
Precision Neuroscience and Team Gleason Partner to Give the ALS Community a Voice in Brain–Computer Interface Development
16/11/2026 -
VIVUS Announces Preferred Formulary Status for PANCREAZE® Across Major National Medicare Formulary
16/11/2026 -
AliveCor and PulseAI Partner to Bring Advanced Cardiac AI Determinations and Clinical Care Platform to Major Consumer Wearables
16/11/2026 -
Allarta Life Science moves Canadian-developed type 1 diabetes cell therapy closer to the clinic with Breakthrough T1D award
16/11/2026 -
INVO Fertility Reports Third Quarter 2026 Results Highlighting 28% Clinic Revenue Growth and Continued Positive Clinic-Level Adjusted EBITDA
16/11/2026 -
Daré Bioscience Receives Approximately $852,000 in Additional Grant Funding
16/11/2026 -
Range Impact Reports 3Q 2026 Financial Results
16/11/2026 -
Rapid Micro Biosystems Signs Definitive Agreement to be Acquired by Merck KGaA, Darmstadt, Germany
16/11/2026 -
Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results
16/11/2026 -
Regional Health Properties Reports Third Quarter 2026 Results
16/11/2026 -
Pear Health Labs Launches Pear Health Companion, an Agentic AI Platform for Health Plans and Providers
16/11/2026 -
EAACI connects allergy research with public action on anaphylaxis in Utrecht
16/11/2026
Pages